SOPHARMA (SPH): current report 4 inf. za kfn12.2012 ENG - raport 4
Raport ESPI
UNI - EN REPORT No 4/2013
Podstawa prawna:
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
The Board of Directors of Sopharma AD (the "Company") notifies that for December 2012 Sopharma AD realized decrease of sales revenues of 13% compared to the same period of 2011, including 9% decrease of domestic sales and 17% decrease of export sales.
During the past twelve months Sopharma AD recorded an increase of sales revenues of 0.35%, including 9% decrease of domestic sales and 5% increase of export sales compared to 2011.
Annexes:
File;
